GeneDx Holdings (WGS) Tops Q3 EPS by 8c; Offers Guidance

GeneDx Holdings (NASDAQ: WGS) reported Q3 EPS of $0.49, $0.08 better than the analyst estimate of $0.41. Revenue for the quarter came in at $116.7 million versus the consensus estimate of $104.33 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $425-428 million, versus the consensus of $411.7 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• Citi Starts Banco Mercantil do Brasil (BMEB4:BZ) at Buy